Do not self-prescribe high-dose B12 based on non-specific symptoms like fatigue without medical assessment
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
If treatment isnt appropriate for you, the provider will not issue a prescription
Evidently, understanding these mechanisms helps you make informed decisions about your recovery journey
While GHK-Cu has been studied primarily in dermatological contexts, its upregulation of collagen types I, III, and IV, along with fibronectin and proteoglycans, suggests potential musculotendinous relevance that awaits systematic investigation in athletic populations